MS Stock Analysis: Morgan Stanley | NYSE
Capital Markets | NYSE, USA | Market Cap: 341.690m USD | 12M Return: 53.7% | US6174464486 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.01B
EPS Trend: 98.0%
Qual. Beats: 4
Rev. Trend: 99.2%
Qual. Beats: 5
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Morgan Stanley (NYSE: MS) is a global financial holding company founded in 1924 and headquartered in New York. It operates through three core segments: Institutional Securities, Wealth Management, and Investment Management, serving corporations, governments, financial institutions, and individuals across the Americas, Asia, Europe, the Middle East, and Africa.
The Institutional Securities segment generates investment-banking fees from underwriting debt and equity offerings, mergers and acquisitions advisory, restructurings, and project finance, and also runs market-making, prime brokerage, and financing activities in equities and fixed income. The Wealth Management segment provides advisor-led and self-directed brokerage, investment advisory, custody, cash management, lending products (including securities-based and residential real estate loans), and retirement plan services, giving the firm a sizable base of recurring fee-based revenue. The Investment Management segment offers equity, fixed income, alternatives, and liquidity/overlay services to institutional and individual clients such as pension plans, foundations, endowments, sovereign wealth funds, and insurance companies.
Within the Financials sector, Morgan Stanley is classified in the Investment Banking & Brokerage sub-industry, a group whose earnings tend to be split between cyclical capital-markets activity and more stable, fee-driven wealth and asset management businesses. The firms mix of advisory, trading, lending, and long-term asset and wealth management is intended to balance revenue across economic cycles, with wealth and investment management typically providing a larger share of steady income and institutional securities contributing more market-sensitive results.
- Wealth Management fee revenues grow on expanding advisor-led AUM
- Investment banking advisory revenue rises on M&A recovery
- Net interest income moves with Fed rate cuts
| Net Income: 20.2b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 0.61 > 1.0 |
| NWC/Revenue: 155.5% < 20% (prev -353.8%; Δ 509.3% < -1%) |
| CFO/TA -0.01 > 3% & CFO -15.6b > Net Income 20.2b |
| Net Debt (-341b) to EBITDA (30.6b): -11.16 < 3 |
| Current Ratio: 1.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.59b) vs 12m ago 0.0% < -2% |
| Gross Margin: 59.72% > 18% (prev 56.26%; Δ 3.46% > 0.5%) |
| Asset Turnover: 8.35% > 50% (prev 8.01%; Δ 0.35% > 0%) |
| Interest Coverage Ratio: 0.52 > 6 (EBIT TTM 26.2b / Interest Expense TTM 50.8b) |
| A: 0.12 (Total Current Assets 1030b - Total Current Liabilities 834b) / Total Assets 1675b |
| B: 0.07 (Retained Earnings 123b / Total Assets 1675b) |
| C: 0.02 (EBIT TTM 26.2b / Avg Total Assets 1514b) |
| D: 0.07 (Book Value of Equity 110b / Total Liabilities 1564b) |
| Altman-Z'' = 1.20 = BB |
| DSRI: 1.32 (Receivables 151b/98.3b, Revenue 127b/108b) |
| GMI: 0.94 (GM 56.26% / 59.72%) |
| AQI: 0.50 (AQ_t 0.38 / AQ_t-1 0.77) |
| SGI: 1.17 (Revenue 127b / 108b) |
| TATA: 0.02 (NI 20.2b - CFO -15.6b) / TA 1675b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of August 19, 2026, the stock is trading at USD 217.55 with a total of 2,199,165 shares traded. Over the past week, the price has changed by +1.15%, over one month by +3.70%, over three months by +13.52% and over the past year by +53.67%.
Current recommended Stop Loss: 210.40 (which is 3.3% or 1.3 ATR below the current price).
Morgan Stanley has received a consensus analysts rating of 3.68. Therefore, it is recommended to hold MS.
- StrongBuy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 236.6 | 8.8% |
P/E Trailing = 17.5574
P/E Forward = 17.331
P/S = 4.3903
P/B = 3.176
P/EG = 2.0405
Revenue TTM = 127b USD
EBIT TTM = 26.2b USD
EBITDA TTM = 30.6b USD
Long Term Debt = 391b USD (from longTermDebt, last quarter)
Short Term Debt = 132b USD (from shortTermDebt, last quarter)
Debt = 525b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -341b USD (calculated: Debt 525b - CCE 866b)
Enterprise Value = 199.9m USD (342b + Debt 525b - CCE 866b)
Interest Coverage Ratio = 0.52 (Ebit TTM 26.2b / Interest Expense TTM 50.8b)
EV/FCF = -0.01x (Enterprise Value 199.9m / FCF TTM -15.7b)
FCF Yield = -7.84k% (FCF TTM -15.7b / Enterprise Value 199.9m)
FCF Margin = -12.40% (FCF TTM -15.7b / Revenue TTM 127b)
Net Margin = 15.99% (Net Income TTM 20.2b / Revenue TTM 127b)
Gross Margin = 59.72% ((Revenue TTM 127b - Cost of Revenue TTM 51.0b) / Revenue TTM)
Gross Margin QoQ = 61.65% (prev 61.79%)
Tobins Q-Ratio = 0.00 (Enterprise Value 199.9m / Total Assets 1675b)
Interest Expense / Debt = 9.68% (Interest Expense 50.8b / Debt 525b)
Taxrate = 22.09% (5.78b / 26.1b)
NOPAT = 20.4b (EBIT 26.2b * (1 - 22.09%))
Current Ratio = 1.24 (Total Current Assets 1030b / Total Current Liabilities 834b)
Debt / Equity = 4.75 (Debt 525b / totalStockholderEquity, last quarter 110b)
Debt / EBITDA = -11.16 (Net Debt -341b / EBITDA 30.6b)
Debt / FCF = 21.77 (negative FCF - burning cash) (Net Debt -341b / FCF TTM -15.7b)
Total Stockholder Equity = 112b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.34% (Net Income 20.2b / Total Assets 1675b)
RoE = 18.13% (Net Income TTM 20.2b / Total Stockholder Equity 112b)
RoCE = 5.21% (EBIT 26.2b / Capital Employed (Equity 112b + L.T.Debt 391b))
RoIC = 2.11% (NOPAT 20.4b / Invested Capital 967b)
WACC = 9.07% (E(342b)/V(866b) * Re(11.42%) + D(525b)/V(866b) * Rd(9.68%) * (1-Tc(0.22)))
Discount Rate = 11.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.92 | Cagr: -0.64%
[DCF] Fair Price = unknown (Cash Flow -15.7b)
EPS Correlation: 98.01 | EPS CAGR: 36.10% | SUE: 3.07 | # QB: 4
Revenue Correlation: 99.19 | Revenue CAGR: 14.21% | SUE: 1.02 | # QB: 5
EPS current Quarter (2026-09-30): EPS=3.16 | Chg30d=+8.40% | Revisions=+44% | Analysts=14
EPS current Year (2026-12-31): EPS=12.98 | Chg30d=+7.96% | Revisions=+85% | GrowthEPS=+27.1% | GrowthRev=+17.0%
EPS next Year (2027-12-31): EPS=13.65 | Chg30d=+5.99% | Revisions=+86% | GrowthEPS=+5.2% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +83% (up=46, down=3)